logo
‘Momentum Meets Reality,' Says Barclays About Tesla Stock

‘Momentum Meets Reality,' Says Barclays About Tesla Stock

Tesla (NASDAQ:TSLA) stock took a beating last Thursday, as Elon Musk's powers of persuasion might not be what they used to be. Despite the CEO's best efforts to convince investors that the company's future lies in its AI and Robotaxi initiatives, Wall Street focused instead on the EV leader's underwhelming Q2 results.
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Those numbers left little room for optimism. Revenue fell by 11.8% year-over-year to $22.49 billion, missing the Street's $22.74 billion forecast. Operating income slid to $0.9 billion, a 42% drop from the year-ago quarter. The end result was adjusted EPS of $0.40, falling short of expectations by $0.03.
But beyond the headline misses, what truly spooked investors were the signals about what lies ahead. Tesla now faces a growing list of challenges that could further weigh on performance. With the U.S. EV tax credit set to expire at the end of Q3, even Musk acknowledged that the company might endure a few 'rough quarters.' That outlook is further clouded by the impact of tariffs and legislative changes –particularly Trump's One Big Beautiful Bill, which eliminated penalties tied to NHTSA CAFE emissions standards. This change is expected to drag on high-margin regulatory credit sales.
For Barclays analyst Dan Levy, what's become 'abundantly clear' for Tesla over the past couple of years – particularly in the last year – is the 'widening gulf between narrative and fundamentals, with the stock increasingly disconnected from fundamentals.' This quarter 'further reinforced that gulf.'
Still, Musk isn't shying away from promoting the bigger vision. He reiterated that Tesla's future reaches far beyond cars, spotlighting AI and robotics as the company's next frontier. From Robotaxis and Optimus to a newly envisioned 'master plan' for a post-autonomy world, the CEO painted a picture of a company leading the charge in real-world AI. Musk even floated the idea of closer collaboration with xAI to bolster Tesla's technological edge.
'Alongside comments of expansion in Robotaxi,' says Levy, 'we believe the narrative remains intact.'
However, a compelling narrative can only do so much when fundamentals are shaky. As Levy pointed out, Tesla's core business remains choppy, and could worsen in the quarters ahead. Even the anticipated low-cost model, now likely arriving in Q4, may underwhelm if it's merely a simplified Model Y with limited appeal.
In the end, the earnings call seemed tailored to reassure long-term believers in Tesla's AI potential rather than to win over skeptics focused on near-term performance. The lack of new detail on Robotaxi progress didn't help, though bulls may pin their hopes on the upcoming AGM in November, which could reinforce the AI story.
'It is the long-term narrative which has kept the stock elevated,' Levy noted. 'Yet for the very near term, the air pocket in fundamentals may be a reminder that fundamentals don't matter… until they matter.'
Judging by the market's reaction, that moment may be arriving. For now, Levy assigns Tesla shares an Equal Weight (i.e., Neutral) rating, with a $275 price target, implying potential downside of 13% from current levels. (To watch Levy's track record, click here)
Looking beyond Levy, sentiment across Wall Street remains divided. TSLA stock holds a consensus rating of Hold, based on 14 Buys, 14 Holds, and 7 Sells. The average price target of $314.14 suggests shares will stay rangebound for the time being. (See TSLA stock forecast)
To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Qualcomm (QCOM) Q2 Earnings Preview: What to Expect From Upcoming Report
Qualcomm (QCOM) Q2 Earnings Preview: What to Expect From Upcoming Report

Yahoo

time3 minutes ago

  • Yahoo

Qualcomm (QCOM) Q2 Earnings Preview: What to Expect From Upcoming Report

July 29- Qualcomm (NASDAQ:QCOM) will reveal Q3 FY2025 results on July 30 after the market close. Wall Street expects adjusted EPS of $2.71, a 16.3% rise from a year ago, and revenue of $10.34 billion, up 10.1%. Investors eye the report amid worries that Apple (NASDAQ:AAPL) will shift to in?house modem chips next year, potentially trimming Qualcomm's handset chip sales. Smartphone market pressures and tariff risks in China also weigh on sentiment. Warning! GuruFocus has detected 6 Warning Signs with QCOM. Still, analysts note Qualcomm's growing footprint in IoT, automotive and edge AI. Bernstein's Stacy Rasgon keeps a Buy rating with a $185 target, calling Qualcomm heavily out of favor yet undervalued given its diverse product lineup and expected double?digit earnings growth. He says it's worth keeping on investors' radar. KeyBanc envisions wider semiconductor power with the help of demand in A as well as new product ramps. It predicts positive prospects of Qualcomm in Q3 but warns that second part of 2025 can have backdrafts due to Apple moving to other modems and sluggish Android market in China. The results will help to understand what degree of offset of challenges related to the handset is possible to be achieved by the divisions, which are engaged with non-smartphone, and whether Qualcomm will be able to quality its growth trend up to the end of the year. Based on the one year price targets offered by 30 analysts, the average target price for Qualcomm Inc is $177.50 with a high estimate of $225.00 and a low estimate of $140.00. The average target implies a upside of +10.21% from the current price of $161.05. Based on GuruFocus estimates, the estimated GF Value for Qualcomm Inc in one year is $160.62, suggesting a downside of -0.27% from the current price of $161.05. Gf value is Gurufocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. For deeper insights, visit the forecast page. This article first appeared on GuruFocus.

Vor Biopharma (VOR) Jumps 10% on Addition of 2 CEOs to Board
Vor Biopharma (VOR) Jumps 10% on Addition of 2 CEOs to Board

Yahoo

time3 minutes ago

  • Yahoo

Vor Biopharma (VOR) Jumps 10% on Addition of 2 CEOs to Board

We recently published . Vor Biopharma Inc. (NASDAQ:VOR) is one of the best-performing stocks on Monday. Vor Biopharma extended its winning streak to a fourth consecutive day on Monday, jumping 10 percent to close at $2.42 apiece and bucking the decline in the overall healthcare sector, as investors continued to load up positions following the addition of two CEOs in its board. Early last week, Vor Biopharma Inc. (NASDAQ:VOR) announced the addition of Alexander Cumbo and Michel Detheux to its board of directors, sparking confidence among investors amid ongoing efforts to strengthen leadership and strategic direction. Cumbo currently serves as president and CEO of Solid Biosciences. He was also the founding CEO of AavantiBio and brings more than 30 years of commercial and executive leadership, including nearly eight years at Sarepta Therapeutics, where he most recently served as Executive Vice President and Chief Commercial Officer. Meanwhile, Detheux is the president and CEO of iTeos Therapeutics. Under his leadership, iTeos raised over $1 billion in capital, completed a successful IPO, and secured a landmark $2 billion partnership with GSK to co-develop and commercialize the company's lead anti-TIGIT antibody. Copyright: nimon / 123RF Stock Photo In a statement, Vor Biopharma Inc. (NASDAQ:VOR) said that Cumbo and Detheux's addition is invaluable as the company advances telitacicept through late-stage development and expands its long-term vision to bring transformative therapies to patients with autoimmune disease. While we acknowledge the potential of VOR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Super Micro (SMCI) Rallies 10.2% as US Freezes Export Curbs to China
Super Micro (SMCI) Rallies 10.2% as US Freezes Export Curbs to China

Yahoo

time3 minutes ago

  • Yahoo

Super Micro (SMCI) Rallies 10.2% as US Freezes Export Curbs to China

We recently published . Super Micro Computer, Inc. (NASDAQ:SMCI) is one of the best-performing stocks on Monday. Super Micro jumped for a fourth straight day on Monday, adding 10.24 percent to close at $60.05 apiece as investors cheered President Donald Trump's decision to freeze export restrictions on technology products to China as Washington and Beijing resume trade negotiations. The US and China will meet in Stockholm for a third round of trade talks on Monday, following previous meetings in Geneva and London. Known for its AI-focused server systems, Super Micro Computer, Inc. (NASDAQ:SMCI) is one of the companies benefiting from increased technology spending this year. Year-to-date, its stock has gone up by almost 100 percent as more companies globally build large artificial intelligence workloads. Copyright: wavebreakmediamicro / 123RF Stock Photo In other developments, Super Micro Computer, Inc. (NASDAQ:SMCI) is set to announce the results of its earnings performance for the fourth quarter of fiscal year 2025 after market close on August 5. An investor call will be held on the same day to elaborate on the results. While we acknowledge the potential of SMCI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store